Table 1.
Stage (Class) | Description |
---|---|
A | Patients with increased risk of developing HF but with normal cardiac function and chamber size. Examples: univentricular heart, previous exposure to anthracycline, Duchenne muscular dystrophy, congenitally corrected transposition of the great arteries, h/o familial dilated cardiomyopathy |
B | Patients with abnormal cardiac morphology or function with no past or current symptoms of HF. Examples: asymptomatic dilated LV, isolated LV noncompaction |
C | Patients with past or current HF symptoms and structural or functional heart disease |
D | Patients with end-stage HF requiring continuous infusion of inotropic agents, mechanical circulatory support, cardiac transplantation, or hospice care |
HF = heart failure, LV = left ventricle.